These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 11182078)

  • 1. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases.
    Sherman MY; Goldberg AL
    Neuron; 2001 Jan; 29(1):15-32. PubMed ID: 11182078
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of heat shock proteins during polyglutamine neurodegeneration: mechanisms and hypothesis.
    Wyttenbach A
    J Mol Neurosci; 2004; 23(1-2):69-96. PubMed ID: 15126694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of chaperones in polyglutamine disease.
    Opal P; Zoghbi HY
    Trends Mol Med; 2002 May; 8(5):232-6. PubMed ID: 12067633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of molecular chaperones in neurodegenerative disorders.
    Meriin AB; Sherman MY
    Int J Hyperthermia; 2005 Aug; 21(5):403-19. PubMed ID: 16048838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of heat shock proteins as chaperones on several human diseases.
    Mellati AA
    Saudi Med J; 2006 Sep; 27(9):1302-5. PubMed ID: 16951762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sick chaperones, cellular stress, and disease.
    Macario AJ; Conway de Macario E
    N Engl J Med; 2005 Oct; 353(14):1489-501. PubMed ID: 16207851
    [No Abstract]   [Full Text] [Related]  

  • 7. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular biology of polyglutamine diseases].
    Owecki M; Kozubski W
    Postepy Hig Med Dosw; 2002; 56(6):779-88. PubMed ID: 12661407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unfolding the promise of translational targeting in neurodegenerative disease.
    Drake TM
    Neuromolecular Med; 2015 Jun; 17(2):147-57. PubMed ID: 25697885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of chaperones on polyglutamine diseases.
    Kobayashi Y; Sobue G
    Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):165-8. PubMed ID: 11719246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma is a target for binding and folding by both Escherichia coli chaperone model systems GroEL/GroES and DnaK/DnaJ/GrpE.
    Vandenbroeck K; Billiau A
    Biochimie; 1998; 80(8-9):729-37. PubMed ID: 9865495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging.
    Morimoto RI
    Genes Dev; 2008 Jun; 22(11):1427-38. PubMed ID: 18519635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders.
    Bose S; Cho J
    Ageing Res Rev; 2017 May; 35():155-175. PubMed ID: 27702699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation.
    McLean PJ; Kawamata H; Shariff S; Hewett J; Sharma N; Ueda K; Breakefield XO; Hyman BT
    J Neurochem; 2002 Nov; 83(4):846-54. PubMed ID: 12421356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock proteins: therapeutic drug targets for chronic neurodegeneration?
    Sajjad MU; Samson B; Wyttenbach A
    Curr Pharm Biotechnol; 2010 Feb; 11(2):198-215. PubMed ID: 20166961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyglutamine protein aggregates are dynamic.
    Kim S; Nollen EA; Kitagawa K; Bindokas VP; Morimoto RI
    Nat Cell Biol; 2002 Oct; 4(10):826-31. PubMed ID: 12360295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.
    Duncan EJ; Cheetham ME; Chapple JP; van der Spuy J
    Subcell Biochem; 2015; 78():243-73. PubMed ID: 25487025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock proteins; an overview.
    Tutar L; Tutar Y
    Curr Pharm Biotechnol; 2010 Feb; 11(2):216-22. PubMed ID: 20170474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transglutaminase-catalyzed post-translational modifications of proteins in the nervous system and their possible involvement in neurodegenerative diseases.
    De Vivo G; Gentile V
    CNS Neurol Disord Drug Targets; 2008 Oct; 7(4):370-5. PubMed ID: 18991665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein folding and association: in vitro studies for self-organization and targeting in the cell.
    Jaenicke R
    Curr Top Cell Regul; 1996; 34():209-314. PubMed ID: 8646849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.